Annette Logan-Parker: A Hemophilia B Breakthrough – From Weekly Infusions to One Treatment
Annette Logan-Parker, Founder and Chief Advocacy and Innovation Officer at Cure 4 The Kids Foundation, Innovation Council Member at Coalition Against Childhood Cancer (CAC2), shared on LinkedIn:
”He flew from Arizona to Las Vegas for a single infusion…and never needed another one.
For 39 years, this patient lived with hemophilia B.
That meant intravenous infusions of clotting factor every week, sometimes multiple times a week, just to prevent a bleed that could put him in the hospital.
Every week. For nearly four decades. That was his life.
In 2024, he came to our clinic and received Hemgenix (an FDA-approved gene therapy that delivers a working copy of the gene his body was missing).
One infusion. One afternoon.
More than a year later, his body is producing its own clotting factor. No more weekly treatments. No more planning his entire life around his next infusion.
Cure 4 The Kids Foundation was the first center in Nevada to administer this therapy, and one of only a handful on the entire West Coast.
This is what research looks like when it reaches the bedside. And it’s why Research Recognition Week matters.
Read the full story on our blog, including what families need to know about gene therapy, who’s eligible, and what’s coming next.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?